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Central extracorporeal membrane 
oxygenation (ECMO) provides physiological flow 
to the body in an antegrade patten; in addition, it 
offloads the left ventricle and avoids the 
complications of peripheral ECMO, including leg 
ischemia [1]. Stunned myocardium is a viable 
myocardium salvaged by coronary reperfusion 
with prolonged postischemic dysfunction after 
reperfusion, and this must be differentiated from 
hibernating myocardium, which improves after 
reperfusion [2].  
The role of ECMO as a bridge to recovery in 
patients with stunned myocardium after coronary 
artery bypass grafting (CABG) is the subject of 
ongoing research. High-risk patients present to 
CABG increasingly, and the risk of mortality is high, 
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Abstract 
Background: The role of central extracorporeal membrane oxygenation (ECMO) 
post coronary artery bypass grafting (CABG) in older patients is debatable. The 
objectives of our study were to investigate the role of central veno-arterial (V-A) 
ECMO as a bridge to recovery in patients with myocardial stunning after CABG and 
its effect on mortality in this group of patients. 
Methods: Seventy-five patients had central ECMO as a bridge to recovery after 
CABG because of myocardial stunning; 45 of them (60%) had survived (group 1), and 
mortality occurred in 30 patients (40%) (group 2). Preoperative risk factors such as 
hypertension, stroke, and renal failure were comparable between groups. In non-
survivors, left main disease was more common (19 (63.3%) vs. 13 (28.9%); p= 0.003) 
and SYNTAX score was higher (Median 33 (25th- 75th percentiles); 33 (29- 35) vs. 
26 (25- 32); p< 0.001).  
Results: Cross-clamp time was shorter in group 1 (58 minutes; (52-62) vs 115.5 
minutes; (84- 161) in group 2; p< 0.001). Cardiopulmonary bypass time was shorter 
in group 1 compared to group 2 (83; (70-90) vs. 155.5; (60 -120) minutes; p< 0.001). 
ECMO duration was longer in group 2 (6 days; (6-7) vs. 3 days; (3-4); p<0.001). Stroke 
occurred in 10 patients (33.33%) in group 2 vs. 1 patient (2.22%) in groups 1; p< 
0.001. Longer cross-clamp (OR: 1.61, 95% CI: 1.11- 2.31, p= 0.011) and bypass time 
(OR: 1.76; 95% CI: 1.57- 1.99; p= 0.048) predicted postoperative mortality.  
Conclusion: Central ven-arterial extramembrane oxygenation can be used as a 
bridge to recovery in patients with stunned myocardium post coronary bypass 
grafting, especially in centers where heart transplantation and ventricular assist 












especially in patients with left ventricular 
dysfunction and left main disease. The impact of 
ECMO on those patients is controversial, and 
factors affecting mortality vary widely. Therefore, 
we investigated the role of central veno-arterial 
(V-A) ECMO as a bridge to recovery in post-CABG 
myocardial stunning and its effect on mortality in 
this group of patients. 
Patients and Methods: 
Study design and patients: 
This is a retrospective cohort study that was 
conducted from January 2010 till January 2020. 
During this period, 75 patients had central V-A 
ECMO as a bridge to recovery post-CABG 
myocardial stunning; 60% of them (n=45) had 
survived and successfully weaned from ECMO 
(group 1), and 40% of them (n=30) died (group 2). 
The data of those 75 patients were collected, and 
patients were assigned to either group according 
to the outcome. 
The data collected included preoperative 
variables: age, sex, left main disease, SYNTAX 
score, and comorbidities, such as hypertension, 
preoperative stroke, and renal failure. Operative 
data included ischemic and bypass times, and the 
number of coronary bypass grafts. Postoperative 
data included complications from central ECMO as 
disseminated intravascular coagulation (DIC), 
acute kindy injury (AKI), intracerebral hemorrhage 
as well as the duration of ECMO. 
Data collection was approved by the 
Institutional Review Board, and patients’ consent 
was waived.  
We included patients who had elective three 
or four vessels CABG, including left main disease 
with depressed myocardial function (ejection 
fraction (EF) < 40%) and patients aged more than 
50 years. Postoperatively, central ECMO was 
inserted after the failure of weaning from 
cardiopulmonary bypass (CPB) with maximum 
inotropes and intra-aortic balloon pump (IABP) 
insertion. V-A ECMO was inserted centrally, and 
the sternum was left open.  
We excluded young aged patients less than 50 
years old because, in those patients, ECMO would 
be a bridge for either LVAD or heart transplant. 
Patients who had an emergency CABG or a 
concomitant procedure as aortic valve surgery or 
patients with ischemic mitral regurge and off-
pump CABG were excluded. We excluded patients 
with right ventricular (RV) failure post-CABG 
because they were candidates for biventricular 
assisted devices (BIVAD).  
Surgical procedures: 
Central ECMO was performed through direct 
surgical cannulation of the right atrium and aorta, 
which were already done during the primary 
procedure. Left ventricular (LV) decompression 
was performed with placing a vent via the right 
superior pulmonary vein (direct LV apical vent 
was the second option) [3]. The size of the 
cannulae depends on the body surface area, the 
calculated flow of the ECMO. Lactate levels were 
followed up to monitor tissue perfusion during 
ECMO perfusion. The cannulae were secured in 
their position to prevent cannulae displacement. 
Fixation of the cannulae was done to the skin at 
different levels, and the patients were heavily 
sedated with a muscle relaxant to avoid body 
movement with the possibility of decannulation 
[4]. 
Table 1: Preoperative patients’ characteristics. Continuous variables are presented as median (25th and 75th 
percentiles) and categorical variables as number and percent 
Survivors (Group 1; n=45) Non-survivors (Group 2; n=30) p-value 
Age (Years) 67 (63- 69) 66 (64- 70) 0.97 
Male  30 (66.67%) 20 (66.67%) ˃0.99 
Left main disease 13 (28.89%) 19 (63.33%) 0.003 
SYNTAX score 26 (25- 32) 33 (29- 35) <0.001 
Hypertension 33 (73.33%) 21 (70%) 0.797 
Stroke 4 (8.89%) 1 (3.33%) 0.642 
Renal failure 2 (4.44%) 3 (10%) 0.383 





At the end of the procedure, the chest was left 
open with an occlusive dressing or using a dacron 
patch, which facilitated reopening, especially if 
there were general ooze around the cannulae 
from anticoagulation. LV output was preserved by 
following the pulsatile wave of the native heart on 
the arterial monitor as ECMO flow was non-
pulsatile. Follow up echocardiography was used to 
follow  the LV ejection fraction as well as 
monitoring  the recovery of myocardial function 
and guide us through the process of 
weaning.Continuous intravenous heparin was 
installed hourly with close monitoring of activated 
clotting time (ACT) and activated partial 
thromboplastin time (aPTT), which must be 
regularly done to avoid excessive bleeding from 
over anticoagulation or ECMO membrane clotting 
from inadequate anticoagulation [4]. 
Statistical Analysis 
Continuous variables were presented as the 
50th (median), 25th and 75th percentiles and 
were compared using the Wilcoxon rank-sum test. 
Nominal variables were presented as number and 
percent and were compared using the Chi-square 
or Fisher exact test when the expected frequency 
is less than 5. 
Univariable logistic regression analysis was 
used to identify the factors affecting mortality. 
Variables with p-value <0.25 in the univariable 
analysis were included in a multivariable logistic 
regression analysis. The goodness of fit was tested 
with the Hosmer-Lemeshow test, and the p-value 
of the model was 0.99, indicating the suitability of 
the model. All analyses were performed using 
Stata 16 (Stata Corp- College Station- Texas- USA). 
Results 
Preoperative patients’ characteristics: 
Seventy-five patients had central ECMO as a 
bridge to recovery in post-CABG myocardial 
stunning; 45 of them survived and mortality 
occurred in 30 patients (40%). Preoperative 
variables were compared between both groups. 
No statistical significance was detected between 
both groups regarding preoperative risk factors as 
diabetes, hypertension, stroke, and renal failure. 
(Table 1) In non-survivors, left main disease was 
more common (19 (63.3%) vs. 13 (28.9%); p= 
0.003) and SYNTAX score was higher (Median 33 
(25th- 75th percentiles); 33 (29- 35) vs. 26 (25- 32); 
p< 0.001).  
Operative data: 
Cross-clamp and CPB times were statistically 
different between both groups where cross-clamp 
time in survivors’ group was 58 minutes (25th- 
75th percentiles: 52-62) compared to that in the 
non-survivor group (median 115.5 minutes; 84- 
161). CPB time in survivors was 83 minutes (70-90) 
compared to 155.5 minutes (60 -120) in the non-
survivors (Table 2). 
Postoperative outcomes: 
Longer duration of ECMO was recorded in non-
survivors (median 6; 6-7 days) compared to 3 days 
in survivors (3-4). Causes of death were DIC (n= 14; 
46.67%), stroke (n= 10; 33.33%) and renal failure 
(n= 10; 33.33%) (Table 3). Predictors of mortality 
are shown in Table 4. 
Discussion 
Postcardiotomy cardiogenic shock (PCCS) 
occurring after CABG is associated with high 
mortality [6, 7], and V-A ECMO has been utilized 
as a salvage mechanical circulatory support in 
those patients [8, 9]. The decisions of using such 
an invasive technique or its weaning remain 
controversial. 
Table 2: Operative characteristics of the patients. Continuous variables are presented as median (25th and 75th 
percentiles) and categorical variables as number and percent 
Survivors (Group 1; n= 45) Non-survivors (Group 2; n=30) p-value 
Cross-clamp time (minutes) 58 (52- 62) 115.5 (60 -120) <0.001 
CPB time (minutes) 83 (70 – 90) 155.5 (84- 161) <0.001 
Number of grafts 4 (3- 4) 4 (3- 4) 0.056 
CPB: cardiopulmonary bypass 




Table 3: Postoperative outcomes. Continuous variables are presented as median (25th and 75th percentiles) and 
categorical variables as number and percent 
Survivors (Group 1; n= 45) Non-survivors (Group 2; n=30) p-value 
Renal failure 11 (24.44%) 10 (33.33%) 0.401 
DIC 0 14 (46.67%) <0.001 
Stroke 1 (2.22%) 10 (33.33%) <0.001 
Duration of ECMO (Days) 3 (3- 4) 6 (6- 7) <0.001 
DIC: disseminated intravascular coagulation; ECMO: extracorporeal circulation 
V-A ECMO in patients with refractory PCCS is used 
as a “bridge to recovery” or as a bridge to 
destination therapy with LVAD or orthotopic 
heart transplantation [10 – 12].Nevertheless, 
central ECMO itself carries a significant risk of 
morbidity, especially if prolonged [13]. In this 
study, we investigated the causes of post-CABG 
myocardial stunning and the relation between 
ischemic time and total bypass time to 
myocardial stunning beside the role of central 
ECMO as a bridge for recovery. Left main disease 
and high SYNTAX score, together with prolonged 
ischemic and bypass times, were associated with 
increased mortality.  
In our study, we found that one of the most 
important predictors of myocardial stunning was 
ischemic and bypass times, and this was reported 
in the literature where Doenst and colleagues 
found that ischemic times greater than 30 min was 
associated with a steadily increasing mortality 
[14]. Furthermore, Al-Sarraf and coworkers found 
that high-risk patients (EuroScore ≥ 6) with 
ischemic times >90 minutes and those with 
ischemic times < 60 min and ≤ 90 minutes were 
respectively 4.7 and 3.1 times more prone to 
death than those with ischemic times ≤ 60 min 
[15]. It was noted that a large number of cases in 
the non-survivor group were with left main 
coronary artery stenosis this was explained with 
inadequate myocardial protection of these 
patients during aortic cross-clamping with the 
classic antegrade cardioplegia that will be unable 
to go through the left coronary artery system due 
to proximal obstruction in the left main trunk and 
this raises the importance of combining both 
techniques of antegrade and retrograde 
cardioplegia in dealing with those patients, and 
this was reported by Onorati and coworkers that 
the combined route of intermittent blood 
cardioplegia allows better results in left main 
stem disease [16] and it was similar to a 
retrospective study conducted by Bar and 
colleagues on patients undergoing CABG surgery 
with valve repair or replacement with long 
ischemic time and receiving antegrade followed 
by retrograde cardioplegia  demonstrating that 
mortality was lower in these patients [17].
Table 4: Logistic regression analysis for factors affecting mortality 
Univariable analysis Multivariable analysis 
OR (95% CI) p-value OR (95% CI) p-value 
Age 0.99 (0.88- 1.12) 0.893 - - 
Gender 1 (0.37- 2.66) 0.99 - - 
Left main disease 4.25 (1.59- 11.37) 0.004 4.45 (0.1-    197.42) 0.44 
SYNTAX score 1.29 (1.14- 1.47) 0.001 0.32 (0.88- 1.98) 0.18 
Hypertension 0.85 (0.31- 2.36) 0.753 - - 
Renal failure 2.39 (0.37- 15.23) 0.357 - - 
Stoke 0.35 (0.037- 3.33) 0.363 - - 
Ischemic time 1.086 (1.04- 1.139) 0.001 1.61 (1.11- 2.31) 0.011 
CPB 1.06 (1.029- 1.08) 0.001 1.76 (1.57- 1.998) 0.048 
Number of grafts 2.63 (0.97- 7.14) 0.058 0.051 (0.0005- 5.57) 0.214 
CI: confidence interval; CPB: cardiopulmonary bypass; OR: odds ratio 




Strong relation was realized between 
mortality and SYNTAX score because increased 
Syntax score denotes the degree of vessel stenosis 
and degree of calcification with more time 
consumed by the surgeon in distal grafting of the 
coronaries and consequently longer ischemic as 
well as bypass times. Central ECMO as a bridge for 
recovery in our center effectively reduced the 
mortality of post-CABG stunned myocardium to 
40%, especially it was the only modality available 
in our center ten years back before the new era of 
LVAD and heart transplant, and this was confirmed 
in the literature by Gregoire and colleagues where 
sixty-five patients (47%) of his study had survived 
till discharged from ICU after central ECMO 
insertion [18]. 
In our center, criteria of weaning depend on a 
lot of parameters : (1) Hemodynamic assessments 
in the form of mean blood pressure >60 mmHg , 
cardiac index >2.4 L/min/m2  with, pulmonary 
capillary wedge pressure <18 mm Hg and central 
venous pressure <18 mmHg.(2) Echocardiographic 
parameters of LV  function, such as LVEF, aortic 
velocity-time integral, and lateral mitral annulus 
peak systolic velocity together with the doppler 
parameters reflecting LV filling pressures (i.e., 
mitral velocities).  
When dealing with ideal duration for V-A 
ECMO, there was a great controversy in literature 
about exact duration, but in our study, it was clear 
that early weaning of ECMO has an essential role 
in reducing the mortality, in the survivors group 
duration was 3 days compared to 6 days in non-
survivors and this produced significant statistical 
effect on mortality and this goes hand in hand with 
what was mentioned by Myles and colleagues 
where survival was highest when weaning was 
done on the fourth day of ECMO and it decreased 
when going into the second week [19]. 
Additionally, the predictive value of ECMO 
duration has been recently discussed by Smith and 
coworkers in their Extracorporeal Life Support 
Organization (ELSO) registry analysis of almost 
2700 patients submitted to VA-ECMO where the 
study showed that best survival was observed with 
VA-ECMO weaning at the fourth day of support 
[19]. Finally, the most common causes of death 
from the increased duration of ECMO were DIC, 
renal failure, and intracerebral hemorrhage from 
anticoagulation or part of hematological failure 
from SIRS. 
Study limitations 
The major limitations are the retrospective 
design and the small sample size as it’s an 
expensive technique that requires trained 
personals including nurses, cardiac surgeons, 
intensivist as well as perfusionist with close 
monitoring and observation of this patient group 
for best outcome beside it needs more 
sophisticated techniques as LVAD or heart 
transplant for better outcome as central ECMO 
may be used as a bridge for other destination 
therapy not only bridge for recovery. 
Conclusion 
Central veno-arterial extracorporeal 
membrane oxygenation can be used as a bridge to 
recovery in patients with stunned myocardium 
post coronary bypass grafting, especially in 
centers where heart transplantation and 
ventricular assist devices are not available. 
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